Chisato Inoue   Sayaka Sobue   Yuka Aoyama   Naoki Mizutani   Yoshiyuki Kawamoto   Yuji Nishizawa   Masatoshi Ichihara   Akihiro Abe   Fumihiko Hayakawa   Motoshi Suzuki   Yoshinori Nozawa   Takashi Murate   
Biochemistry and biophysics reports 15 69-75 2018年9月
Imatinib (IMT), a specific tyrosine kinase inhibitor (TKI), has drastically changed the treatment strategy for Ph+ ALL (Philadelphia chromosome-positive acute lymphoblastic leukemia). However, TKI resistance remains a serious problem for patient p...